Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
talis.bio

See what CB Insights has to offer

Founded Year

2010

Stage

IPO | IPO

Total Raised

$10M

Date of IPO

2/12/2021

Market Cap

0.54B

Stock Price

11.70

About Talis Biomedical

Talis Bio (NASDAQ: TLIS) is developing a high-performance molecular point-of-care (POC) diagnostic platform to enable physician offices and clinics to run reference lab-quality diagnostic laboratory tests for infectious diseases.

Talis Biomedical Headquarter Location

230 Constitution Dr.

Menlo Park, California, 94025,

United States

650-433-3000

Latest Talis Biomedical News

Talis Biomedical To Announce First Quarter 2021 Financial Results On May 11, 2021

May 4, 2021

Talis Biomedical To Announce First Quarter 2021 Financial Results On May 11, 2021 MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release... Author: May 4, 2021 8:00 AM EDT MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the first quarter after market close on Tuesday, May 11, 2021. Talis will host a conference call, beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss financial and operational results. Interested parties may access the live call via telephone by dialing 833-715-1329 for participants in the U.S. or Canada and 430-775-1933 for international callers, using conference ID 7657867. A live and archived webcast of the event can be accessed via the News & Events page of the investor section of Talis Biomedical's website at www.talis.bio . About Talis BiomedicalTalis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care, beginning with COVID-19. The company is developing Talis One, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis is headquartered in Menlo Park, California. For more information, please visit  talis.bio . ContactMedia & InvestorsEmily Faucette ir@talisbio.com 415-595-9407 By

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Talis Biomedical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Talis Biomedical is included in 5 Expert Collections, including Infectious Disease.

I

Infectious Disease

2,330 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

M

Medical Devices

8,753 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

9,302 items

Companies that use or incorporate digital technology into their health/wellness product & service offerings. Only those that have raised funding after 01/01/2010

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health IT

923 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Talis Biomedical Patents

Talis Biomedical has filed 21 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Fluid dynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/25/2020

6/29/2021

Molecular biology, Biotechnology, DNA, Genetics, Molecular biology techniques

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/25/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/29/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Biotechnology, DNA, Genetics, Molecular biology techniques

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Talis Biomedical Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Talis Biomedical Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.